Evidence on ergogenic action of glucocorticoids as a doping agent risk
Systemic administration of glucocorticoids (GCs) is banned by the World Anti-Doping Agency (WADA) during competition. Few studies have examined the effects of GCs on exercise performance, but increasing evidence has shown that short-term GC intake enhances performance in animals and humans. However, there are many health risks associated with GC use. Based on the available evidence, as presented in this article, I conclude that GCs are doping agents and should remain on the WADA`s list of banned products. Because of the complexity of GCs, however, determining the boundaries between their medical use and abuse (eg, in sports) is a constant challenge for the WADA.
© Copyright 2010 The Physician and Sportsmedicine. JTE Multimedia Company. All rights reserved.
| Subjects: | |
|---|---|
| Notations: | biological and medical sciences |
| Published in: | The Physician and Sportsmedicine |
| Language: | English |
| Published: |
2010
|
| Online Access: | http://doi.org/10.3810/psm.2010.10.1817 |
| Volume: | 38 |
| Issue: | 3 |
| Document types: | article |
| Level: | advanced |